Relationship between expression of multidrug resistance protein,PCNA and p53 and its significance in patients with non-small cell lung cancer
ZHAN Ping,YU Li-ke,WAN Ming-yue,ZHANG Yuan-qing,SONG Yong
2008-01-01
Chinese Clinical Oncology
Abstract:Objective:To detect the expression of multidrug resistance protein,PCNA and p53 in non-small cell lung cancer tissues,to investigate their relationship and the significance in patient with non-small cell lung cancer.Methods:Immunohistochemical staining was used to evaluated the expression of proliferating cell nuclear antigen(PCNA),p53,P170 protein,lung resistance protein(LRP),topoisomerase Ⅱ(TopoⅡ) and glutathione S-transferasen(GST-π) in cancer tissues from 70 patients with NSCLC.Results:The positive rate of PCNA,p53,P170,LRP,TopoⅡ and GST-π was 75.7%,60.0%,72.9%,67.1%,27.1% and 78.6% respectively.There was a correlation between the expression of PCNA and p53(r=0.354,P=0.003).There was significant difference in P170 expression with different N-stage and different TNM stage(P=0.016,0.018).There was also significant difference in LRP expression with different histology and TNM stage(P=0.000,0.048).There was also significant difference in GST-π expression with different sizes of primary tumors and TNM stage(P=0.002,0.008,0.028).Spearman analysis showed that there was a positive correlation between the expression of p53 and P170(P=0.003),and between p53 and GST-π(P=0.003).There was no correlation between the expression of PCNA and four multidrug resistance proteins(P>0.05).Conclusion:The expression of multidrug resistance protein(P170,GST-π) is significantly related to p53 protein,but PCNA.It is important to detect both p53 and multidrug resistance protein for predicting the multidrug resistance and prognosis in NSCLC.